Zhengchang Wu | Veterinary Medicine | Best Researcher Award

Published on by China Scientist

Prof. Zhengchang Wu | Veterinary Medicine | Best Researcher Award 

Vote for this Nominee




[poll id=”2″]

Zheng-chang Wu is a Professor in the Department of Animal Science at Yangzhou University, specializing in animal genetics, breeding, and reproduction. He earned his Ph.D. (2017), M.Sc. (2013), and B.Sc. (2011) from Yangzhou University. As a visiting scholar at Agriculture and Agri-Food Canada (2018-2019), he expanded his expertise in livestock genetics. His research focuses on genetic resistance to Escherichia coli infections in pigs, genome-wide association studies, and epigenetic regulation in livestock. He has secured funding from the Jiangsu Agricultural Science and Technology Innovation Fund and the Natural Science Foundation of Jiangsu Province. An accomplished researcher, Dr. Wu has published extensively in high-impact journals, contributing significantly to disease resistance in swine populations.

Prof. Zhengchang Wu | Yangzhou University | China

Profile

SCOPUS ID

🎓Education

  • Zheng-chang Wu pursued his academic journey at Yangzhou University, where he earned his Bachelor of Science degree in 2011. He continued his education at the same institution, obtaining a Master of Science degree in 2013 and a Ph.D. in Agricultural Science in 2017. His academic background has provided him with a strong foundation in animal genetics, breeding, and reproduction.

👨‍🏫Experience

  • Currently serving as a professor in the Department of Animal Sciences at Yangzhou University since September 2023, Zheng-chang Wu has made significant contributions to the field of animal genetics. His professional journey includes an international academic exchange as a visiting scholar at Agriculture and Agri-Food Canada (AAFC) in Ottawa, where he conducted research from May 2018 to May 2019.

🏆Awards and Recognitions

  • Zheng-chang Wu has received recognition for his research through multiple grants and funding projects. He has secured support from the Jiangsu Agricultural Science and Technology Innovation Fund for his study on genome-wide breeding strategies in the context of African Swine Fever. Additionally, his research on the CeRNA regulation mechanism of circ_FUT2 in Escherichia coli F18 resistance in weaned piglets has been funded by the Natural Science Foundation of Jiangsu Province.

💡Skills and Certifications

  • With a deep specialization in animal genetics, breeding, and reproduction, Zheng-chang Wu has developed extensive expertise in molecular biology, genome-wide association studies, and disease resistance mechanisms in pigs. His research integrates advanced genetic analysis techniques, including DNA methylation and RNA sequencing, to enhance breeding strategies and improve animal health.

🔬 Research Focus

  • Zheng-chang Wu’s research primarily explores the genetic mechanisms underlying disease resistance in pigs, with a particular focus on Escherichia coli F18 susceptibility. His studies investigate how genetic modifications, such as DNA methylation and non-coding RNA regulation, influence immune responses and resistance traits. Additionally, his work extends to porcine circovirus type 2 replication, genome-wide breeding strategies, and the functional roles of key genes in animal reproduction and immunity. His findings contribute significantly to animal breeding advancements and livestock disease control strategies.

🌎Conclusion

  • Based on his academic achievements, extensive research output, high-impact publications, and innovative contributions to animal genetics, Zheng-chang Wu is a highly suitable candidate for the Best Researcher Award. His ability to bridge fundamental research with practical applications in veterinary medicine sets him apart as a distinguished researcher in the field.

📖Publications

  • Paeoniflorin Inhibits Porcine Circovirus Type 2 Replication by Inhibiting Autophagy and Targeting AKT/mTOR Signaling

    • Authors: Z. Wu, Zhengchang; L. Yu, Luchen; Y. Hu, Yueqing; W. Bao, Wenbin; S. Wu, Shenglong
    • Journal: Veterinary Sciences, 2025

  • TRIM8 inhibits porcine epidemic diarrhoea virus replication by targeting and ubiquitinately degrading the nucleocapsid protein

    • Authors: Z. Bi, Zhenbin; W. Wang, Wei; S. Gu, Shanshen; W. Bao, Wenbin; H. Wang, Haifei
    • Journal: Veterinary Research, 2025

  • DNA ligase III mediates deoxynivalenol exposure-induced DNA damage in intestinal epithelial cells by regulating oxidative stress and interaction with PCNA

    • Authors: X. Zhu, Xiaoyang; J. Wu, Jiayun; X. Chen, Xiaolei; W. Bao, Wenbin; H. Fan, Hairui
    • Journal: International Journal of Biological Macromolecules, 2024

  • Identification of Tissue Expression Characteristics of Pig ALKBH5 and Its Association with Pathogenic Microbial Infection

    • Authors: Yuan Bian; Y. Xu, Yifan; W. Bao, Wenbin; Z. Wu, Zhengchang
    • Journal: Biology Bulletin, 2024

  • Characterization of the molecular role that ST3GAL1 plays in porcine susceptibility to E. coli F18 infection

    • Authors: Z. Wu, Zhengchang; M. Li, Meiqi; J. Wu, Jiayun; J. Jin, Jian; Y. Wu, Yanqing
    • Journal: International Journal of Biological Macromolecules, 2024

Xiaoxi Liu | Veterinary Medicine | Best Researcher Award

Published on by China Scientist

Assoc. Prof. Dr. Xiaoxi Liu | Veterinary Medicine | Best Researcher Award

Xiaoxi Liu is an Associate Professor at Guangdong Ocean University, specializing in traditional Chinese veterinary medicine and plant extracts. She earned her degree from China Agricultural University in 2017 and has since focused on innovative research in natural therapeutics. Her work includes notable contributions to understanding the anti-inflammatory effects of Siraitia grosvenorii extract. She has led projects funded by the National Natural Science Foundation of China and the Nanhai Scholars Program. With several SCI-indexed publications and patents, Xiaoxi Liu continues to explore the therapeutic potential of plant-based medicine in veterinary science.

Assoc. Prof. Dr. Xiaoxi Liu | Guangdong Ocean University | China

Profile

SCOPUS ID

ORCID ID

🎓 Education

  • Xiaoxi Liu earned her education at China Agricultural University, where she studied from September 2013 to July 2017. During this period, she developed a strong foundation in her field, which has shaped her academic and professional journey.

💼 Experience

  • Since July 2017, Xiaoxi Liu has been working as an Associate Professor at Guangdong Ocean University, where she has contributed significantly to research and teaching in veterinary science and plant-based medicine. Her role also involves mentoring students and leading various research initiatives.

🔥 Awards and Achievements

  • Xiaoxi Liu has been recognized for her innovative research through funding and awards such as the National Natural Science Foundation of China (No. 31902314). She has also received support through the Program for Scientific Research Start-Up Funds of Guangdong Ocean University (101402/R17088) and the prestigious Nanhai Scholars Program of Guangdong Ocean University (No. 002029002005).

🛠️ Skills and Certifications

  • Xiaoxi Liu possesses advanced expertise in traditional Chinese veterinary medicine, with a specialized focus on plant extracts and their applications in mitigating health conditions. She is adept at conducting scientific research, publishing high-quality papers, and designing experimental studies to address critical veterinary issues.

🔬 Research Focus

  • Xiaoxi Liu’s research primarily revolves around traditional Chinese medicine and plant-based therapeutics. Her studies emphasize the effects of plant extracts, particularly Siraitia grosvenorii, on reducing inflammation and improving intestinal health. Through her work, she has demonstrated the potential of mogrosides and other bioactive compounds in alleviating systemic immunosuppressive responses and enhancing the mucus barrier.

🌟Contributions to the Field

  • One of Xiaoxi Liu’s notable contributions is her groundbreaking research on Siraitia grosvenorii extract (SGE). Her findings reveal how its components—including mogrosides, sugars, fatty acids, and organic acids—play a crucial role in reducing inflammation, protecting the intestinal mucus barrier, and promoting the immune system’s response. This research lays the groundwork for better understanding and utilizing traditional Chinese medicine in treating intestinal inflammation.

Conclusion

  • Xiaoxi Liu’s exceptional contributions, demonstrated by her research achievements, patents, and impactful publications, make her an ideal candidate for the “Research for Best Researcher Award.” Her innovative work in traditional Chinese veterinary medicine and plant extracts reflects her unwavering commitment to advancing animal healthcare. Recognizing her with this award would not only honor her contributions but also inspire others in the field to pursue groundbreaking research.

📄Publications

  • Butyrolactone-I from marine fungi alleviates intestinal barrier damage caused by DSS through regulating Lactobacillus johnsonii and its metabolites in the intestine of mice
    Authors: Chen, S., Niu, X., Zhang, Y., Abd El-Aty, A.M., Ju, X.
    Journal: Journal of Nutritional Biochemistry, 2025, 135, 109786
  • Butyrolactone-I from Marine Fungal Metabolites Mitigates Heat-Stress-Induced Apoptosis in IPEC-J2 Cells and Mice Through the ROS/PERK/CHOP Signaling Pathway
    Authors: Niu, X., Chen, S., Wang, X., Abd El-Aty, A.M., Ju, X.
    Journal: Marine Drugs, 2024, 22(12), 564
  • Insights and implications for transcriptomic analysis of heat stress-induced intestinal inflammation in pigs
    Authors: Yu, Z., Yong, Y., Liu, X., Ye, X., Ju, X.
    Journal: BMC Genomics, 2024, 25(1), 1110
  • Network pharmacology analysis of the regulatory effects and mechanisms of ALAE on sow reproduction in vivo and in vitro
    Authors: Zhao, L., Zhang, J., He, J., Ju, X., Liu, X.
    Journal: Journal of Ethnopharmacology, 2024, 334, 118525
  • Baicalin methyl ester prevents the LPS-induced mice intestinal barrier damage in vivo and in vitro via P65/TNF-α/MLCK/ZO-1 signal pathway
    Authors: Liang, M., Sun, X., Guo, M., Ju, X., Liu, X.
    Journal: Biomedicine and Pharmacotherapy, 2024, 180, 117417